Thanks for Reading!

CrownBio’s validated syngeneic tumor models support the transition into the clinic.

• Models Profiled for In Vivo Response to Checkpoint Inhibitors
• A Variety of Cancer Types 
• Orthotopic or Subcutaneous Models 
• Bioluminescent and Metastatic Models

Our syngeneic model data, including RNAseq, tumor growth curve, and response to standard of care agents are available within MuBase^®. Not registered yet? 

Want to interrogate your compound's PD effect or efficacy in vivo?

Ask us about MuScreen™, our large scale staggered syngeneic screening platform to fast track strategies.

Fill in the form and we will be in touch soon!